Patents Represented by Attorney Johnathan M. Dermott
  • Patent number: 8227576
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: July 24, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden